Accelerated Cure Project for multiple sclerosis (MS), with its iConquerMS™ People-Powered Research Network initiative, is collaborating with Quest Diagnostics and the National Multiple Sclerosis Society to study immune response to COVID-19 vaccinations of people living with multiple sclerosis.
The study will employ a decentralized clinical trial model by which Quest's national network of patient service centers will enable participants to conveniently provide periodic blood specimens.
Read more about the study here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.